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Conserved T-cell receptor b chain CDR3 sequences in IgA nephropa- infiltration of the affected tissues in multiple sclerosis in
thy biopsies. humans and in experimental allergic encephalomyelitis
Background. We have previously reported that both ab and gd T
(EAE) showed that the TCR Vb repertoire of patho-cells are involved in the progression of IgA nephropathy (IgAN) to
renal failure. To determine whether the T-cells seen in the interstitium genic T lymphocytes was highly restricted. Strategies us-
represent a generalized inflammatory response or whether they are pro- ing TCR Vb antisera, vaccination with encephalitogenicliferating oligoclonally in response to a particular antigen, we analyzed
T cells, or immunization with TCR Vb peptide have allthe TCR Vb gene usage by T cells infiltrating renal biopsies from
patients with IgAN. been shown to improve progressive disease in experimen-
Methods. Fourteen IgAN patients were divided by clinical criteria tal allergic encephalomyelitis [1–3], and TCR-specific pep-into stable and progressive groups (7 in each group). Reverse transcrip-
tides show therapeutic promise in multiple sclerosis [4].tion-polymerase chain reaction (RT-PCR) and cloning were used to
characterize the expression of TCR Vb families in renal biopsies and However, analyses of TCR repertoire in human autoim-
in peripheral blood lymphocytes. mune diseases have yielded conflicting results. SomeResults. TCR Vb8 was significantly and preferentially expressed in
groups suggest that the TCR repertoire is restricted ormost IgAN kidney biopsies compared with peripheral blood lympho-
cytes from both IgAN patients and healthy controls (P , 0.001). TCR biased in some conditions [5–7], whereas other groups
Vb8 expression was more marked in progressive biopsies than in stable have demonstrated a TCR repertoire that is more diversebiopsies (P , 0.05). Spectratyping of Vb8 RT-PCR products from T cells
[8]. No previous studies are available of analysis of theinfiltrating the kidney showed an intense spectratype band at the short-
est range of amplified CDR3s in the renal biopsies of four patients. TCR Vb gene repertoire in human glomerulonephritis.
Analysis of nucleotide and deduced amino acid sequences of Vb8 PCR
IgA nephropathy (IgAN), characterized by a predomi-products derived from intense spectratype bands from these renal
biopsies revealed a high concordance across the CDR3 region. A nance of glomerular mesangial IgA deposition, has been
conserved amino acid (leucine) at the first position of the nongermline- called the most common form of chronic glomerulone-
encoded nucleotides and diversity (ND) junction of Vb8 was found
phritis throughout the world [9, 10]. The course of IgANat a frequency of 95% in multiple sequences obtained from the renal
biopsies of all four patients examined. was initially considered benign, but now it is recognized
Conclusions. The preferential use of Vb8 with marked similarities that progress to end-stage renal failure will occur in ap-
in the CDR3 region by some renal infiltrating T cells suggests clonal
proximately 25% of these patients over a period of 20expansion of T cells in the kidneys of some IgAN patients. Conserved
amino acids in the TCR CDR3 hypervariable region may contribute years [11]. Despite extensive worldwide investigation,
to the recognition of a particular antigen or set of antigens. the pathogenesis of IgAN is still uncertain. Recent stud-
ies have shown that the extent of T-lymphocyte infiltra-
tion into the renal interstitium is correlated with progres-
The determination of T cell receptor (TCR) variable sion to renal failure and prognosis [12, 13]. The antigen
(V) region gene usage in human autoimmune diseases or antigens recognized by these T cells are unidentified
is of interest for the light it sheds on the molecular basis [11, 14, 15], but the observation suggests that although
of self-reactivity and because repertoire studies may lead antibody deposition is the hallmark of the disease, cell-
to specific immunotherapeutic interventions for the treat- mediated immunity may play a role in progression to
ment of autoimmune diseases [1]. Initial studies of T cell renal failure [12, 13, 16]. Currently, no effective therapy
exists to halt progression.
We have previously reported that both ab and gd TKey words: renal biopsies, CDR3 region, spectratype, amino acid se-
quence, inflammatory response, autoimmune disease. cells are involved in the progression of IgAN to renal
failure [17]. It is unclear whether the T cells seen in theReceived for publication February 6, 1998
interstitium represent a generalized inflammatory re-and in revised form June 30, 1998
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to examine the nature of T cell infiltration into the renal Ethics approval
interstitium and in an attempt to identify potential targets Ethics approval was granted by the Ethics Committee
for immunotherapeutic intervention, we have undertaken at the Royal Alexandra Hospital for Children, West-
an analysis using reverse transcription-polymerase chain mead, Australia.
reaction (RT-PCR), CDR3 size spectratyping and se-
Immunoperoxidase stainingquencing to characterize the TCR Vb repertoire from T
cells infiltrating the kidney of IgAN patients. The results Frozen sections were fixed in acetone and were stained
described here reveal that although TCR Vb repertoire with a primary monoclonal antibody—either anti-CD3
in kidney biopsies of patients with IgAN is diverse, pref- (Dako, Carpinteria, CA, USA) or anti-TCRbF1 (T cell
erential use of Vb8 by renal infiltrating T cells can be Diagnostics, Woburn, MA, USA). The sections were
demonstrated. DNA sequencing of the Vb8 PCR prod- incubated with biotinylated goat antimouse Ig (Dako)
and then with avidin-biotin-peroxidase complex (Dako)ucts derived from spectratypes from four renal biopsies
and diaminobenzidine (DAB) substrate.provided interesting findings, with certain sequences ov-
errepresented in the majority of clones examined, an
RNA extraction and cDNA preparationobservation that implies T cell proliferation in response
Peripheral blood lymphocytes (PBLs) were separatedto a specific antigen or a set of antigens.
on a Ficoll-Hipaque gradient (Pharmacia, Uppsala, Swe-
den). Renal tissue was homogenized in a tissue grinder
METHODS under RNAse free conditions. RNA was isolated from
pelleted PBLs and renal homogenate by acid guanidi-Patient selection
nium thiocyanate-phenol-chloroform extraction usingRenal biopsies were obtained from 14 adult patients
the single-step method of Chomczynski and Sacchi [18].from the Royal Adelaide Hospital with clinical and histo-
One microgram of total RNA in a 10 ml reaction con-logic evidence of IgAN (the presence of dominant or
taining 250 pmol of random hexamer primers (Promega,codominant glomerular mesangial staining for IgA). Pe-
Madison, WI, USA) was heated to 708C for five minutesripheral blood was collected from six patients at the time
and then quenched on ice. The RNA was converted toof renal biopsy and from eight patients three to four
cDNA by incubation for one hour at 378C in a 20 mlyears after the biopsy. The tissue that was used was that
reaction containing 1 3 cDNA first strand synthesisremaining after clinical examination of the samples had
buffer (50 mm Tris-HCl pH 8.3, 75 mm KCl, 3 mm MgCl2,been completed. All biopsies were snap frozen in liquid
10 mm dithiothreitol), 10 units RNasin, 200 units M-nitrogen immediately and were stored at 2808C for a
MuLV reverse transcriptase (Gibco BRL, Grand Island,
period of up to four years. The patients were divided into
NY, USA), and 1 mm of each dNTP (Boehringer Mann-
two clinical groups according to the following criteria.
heim, Mannheim, Germany).
Group 1: IgAN/no progression. Seven biopsies were
from patients with IgAN who at least 12 months after Primers and PCR amplification
biopsy had a normal glomerular filtration rate either Oligonucleotide primers used for TCR Vb1–15, Vb17–
measured or calculated from serum creatinine. 20, and Cb were those described by Panzara et al [19].
Group 2: IgAN/progression. Seven biopsies were from The primer for TCRVb16 was from Choi et al [20]. One
patients with IgAN who at least 12 months after biopsy microliter of each cDNA (50 ng RNA) sample of kidney
showed at least a 50% decline in their glomerular filtra- and 1 ml of each 1 in 50 diluted cDNA (1 ng RNA) sample
tion rate (either as measured or as evidenced by an of PBLs were amplified in a 50 ml reaction containing 1 3
increase in serum creatinine from the normal range to PCR buffer (10 mm Tris-HCl pH 8.3, 50 mm KCl, 1.5
a figure exceeding 200 mmol/liter). mm MgCl2), 0.2 mm of each dNTP, 1.25 units Taq DNA
polymerase (Boehringer Mannheim), 0.2 mm of 39Cb
Controls antisense biotinylated primer and 0.2 mm of 5Vb sense
Control renal tissue was obtained from five patients primer specific for one of the 20 known Vb gene families.
undergoing nephrectomy. Four were children with Wilm’s In all experiments, negative controls without template
tumor. Renal tissue was obtained from the unaffected were included. Primers specific for b-actin (59-AACA
pole of the nephrectomy specimen and showed no histo- CAGTGCTGTCTGGC39 and 59CAACTAAGTCATA
logic evidence of tumor infiltrating lymphocytes. One GTCCGCC-39) served as a positive control for the integ-
positive control nephrectomy specimen was from a pa- rity of the cDNA as well as the success of the PCR.
tient with an infected kidney, which showed extensive The PCR profile was denaturation 958C for one minute,
mononuclear cell infiltrate. Control blood was obtained annealing 608C for one minute, and extension 728C for
one minute for 35 cycles in a DNA thermal cycler (Per-from 12 healthy volunteers.
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kin-Elmer, Norwalk, CT, USA). Aliquots of the ampli- reading for the experimental sample fell on the steep
part of the standard curve.fied products were electrophoresed on 3% NuSieve-Aga-
rose (2:1, wt/wt; FMC Corp., Rockland, ME, USA) gel
Polyacrylamide gel electrophoresisstained with ethidium bromide.
Five microliters of the final PCR reaction volume were
Detection of RT-PCR products withdrawn and mixed with 1 ml of loading buffer. Three
microliters of this solution were loaded onto a 10% poly-The specificity of each PCR Vb gene product was
verified by separate hybridization with a tris (2,29-bipyri- acrylamide sequencing gel. Gels were run until the region
corresponding to 120 to 160 bp was close to the bottomdine) ruthenium (II) chelate-labeled sequence-specific
oligonucleotide probe (59-AGCGACCTCGGGTGGG to optimize resolution.
AACAC-39) directed at segments internal to the ampli-
Silver stainingfied TCR Vb. The electrochemiluminescent signal of the
hybridized probe was detected with a QPCR 5000 system The silver staining procedure used was that described
by Bassam et al and Sanguinetti et al [22, 23]. After(Perkin-Elmer) according to the manufacturer’s recom-
mendations [21]. Under optimized conditions, 1 ml of electrophoresis, polyacrylamide gels were fixed in 10%
acetic acid for 10 minutes, washed with distilled watereach amplified product was denatured in a 20 ml reaction
containing 0.15 m NaOH and 30 mm ethylenediamine (three times, two min each), impregnated with silver
staining solution (1 g/liter AgNO3, 0.0056% formalde-tetraacetic acid at room temperature for at least five
minutes and then at 708C for five minutes. The samples hyde) for 20 minutes, quickly rinsed (5 to 20 sec) with
distilled water, then developed in 30 g/liter Na2CO3,were hybridized at 608C for five minutes in a hybridiza-
tion reaction containing the following: 1 3 PCR buffer 0.0056% formaldehyde, and 400 mg/liter sodium thiosul-
fate at 48C until optimal image contrast was obtained.and 20 pmol of a probe labeled with tris (2,29-bipyridine)
ruthenium (II) chelate in a total volume of 100 ml. The Image development was stopped with 10% acetic acid.
The gel was washed with distilled water and dried.products of each hybridization reaction were transferred
to a separate QPCR System 5000 tube and were captured
Sequencing of Vb RT-PCR productson to 15 ml of a bead suspension containing 2 mg/ml of 4.5
mm magnetic streptavidin-coated Dynabeads (Perkin- cDNA from T cells infiltrating the kidney was ampli-
fied with TCR Vb8 primers as described earlier here.Elmer). Tubes were incubated for 30 minutes at room
temperature with continuous vortexing on the carousel Polyacrylamide gel electrophoresis revealed a strong
band of Vb8 RT-PCR product at the shorter end of theof the QPCR System 5000. At the end of the incubation,
700 ml of QPCR assay buffer was added into each tube CDR3 spectratype in four renal biopsies, and this band
was excised, reamplified, purified by the PCR Prep DNAfor measurement, in duplicate, of the electrochemilum-
inescent signal expressed as arbitrary luminosity units purification system and cloned into the pGEM-T vector
system (Promega). Vb8 RT-PCR product from patientafter subtraction of background. The relative luminosity
of each Vb family member was expressed as a percentage 3050 was also cloned directly without spectratyping.
DNA plasmid preparations were made from individualof the total luminosity detected in all of the Vb regions
for a given sample. colonies using the Wizard plus SV miniprep kit (Pro-
mega). DNA sequencing was performed in both direc-
Optimization of the RT-PCR technique tions by the dideoxy chain determination method on a
Perkin-Elmer Automated Sequencing apparatus.We amplified five quantities of pooled kidney RNA
with Vb8 primer from cycles 23 to 41. Parallel curves
Statistical analysiswere obtained according to initial amount of RNA used.
QPCR luminosity units increased exponentially with the The paired t-test was used to determine whether there
was a significant difference between the Vb percentagenumber of cycles until a plateau was reached. The appro-
priate amount of PBL RNA in each sample was deter- in paired kidney and PBL samples. The independent chi-
square test was used for comparisons of the proportionsmined by PCR amplification of both a strongly expressed
TCR family member (Vb8) and a weakly expressed TCR of Vb usage in individual subjects who had repeated
testing over time.gene family member (Vb19). To establish an amplifica-
tion plateau, two standard curves were constructed from
the mean results of these experiments performed in trip-
RESULTS
licate over a range of serial dilutions of known concentra-
Infiltration of CD31/ab T cells into the kidney oftion of pooled PBL RNA subjected to PCR amplification
IgAN patientsfor TCR Vb8 and Vb19. PCR amplification was per-
formed in duplicate for TCR Vb gene usage in all experi- Immunohistological examination of mononuclear cells
infiltrating renal biopsies using a monoclonal antibodyment samples in dilutions chosen so that the luminosity
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Fig. 1. Polymerase chain reaction (PCR) stan-
dard curves for T cell receptor (TCR) Vb8 (A) and
Vb19 (B) compared in triplicate serial dilutions of
pooled peripheral blood lymphocyte (PBL) RNA
(log scale) to luminosity signal after amplification.
Results are plotted as mean 6 sem.
directed against the TCR Cb chain revealed that exten-
sive ab T-cell infiltration was present in the progressive
IgAN biopsies. Only a minimal number of cells were
detected in the stable biopsies, as we have reported pre-
viously [17].
Characteristics of the RT-PCR assay and controls
Pooled RNA from PBLs of 12 healthy volunteers
yielded readily detectable expression of all 20 TCR Vb
families. Vb8 and Vb19 were used for the construction
of standard curves (Fig. 1) because with electrophoresis
in agar and staining with ethidium bromide, Vb8 is seen
as a strong band and Vb19 is seen as a weak band in
this PCR assay system. A logistic regression analysis of
the sigmoidal curves for each showed that for Vb8, r 2 5
0.9, and for Vb19, r 2 5 0.9. Using these standard curves,
the optimal quantity of PBL RNA for the detection of
the individual TCR Vb products was determined to be
between 0.5 ng and 10 ng. For a RT-PCR assay to avoid
an amplification plateau, the cycle number selected for
the assay must be at a point in which the accumulation
of the PCR products is linear. Figure 2 shows a plot of
the luminosity signal for the Vb8 PCR products that
increased over 25 to 41 cycle range for five quantities of
pooled kidney RNA. Amplification for 35 PCR cycles Fig. 2. Log plots of the TCR Vb8 product versus PCR cycle number.
Plots for five quantities of pooled kidney RNA from 5 ng to 250 ng arefor quantities of RNA between 5 ng to 50 ng was selected
shown. Symbols are: (d) RNA 250 ng; (j) RNA 100 ng; (n) RNA 50to perform the assay for kidney samples because it visual-
ng; (h) RNA 10 ng; (3) RNA 5 ng.
ized Vb8 PCR products within the linear portion of the
amplification curve. We therefore performed all PCR
experiments with 1 ng of RNA for PBL and 50 ng for
kidney. test; P . 0.05). This result is consistent with recent re-
To assess the stability of peripheral blood TCR reper- ports from several groups showing that generally the
toire over time, TCR Vb gene usage analysis of paired patterns of the peripheral TCR repertoire are stable over
samples of peripheral blood from 12 healthy adults a long period of time (from 1 to 4 years) [24, 25].
drawn a year apart was undertaken. This study revealed Similarly processed samples from the unaffected pole
that the usage pattern of Vb genes by peripheral blood of the kidneys removed for Wilm’s tumor demonstrated
T cells was quite constant over time. For each individual, no signal for TCR Vb. Strong signals for all 20 Vb fami-
no significant difference in overall Vb family proportions lies were seen in the sample from the kidney with suppu-
rative pyelonephritis.could be found between the first and second year (x2
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Fig. 3. T cell receptor repertoire from PBLs
and kidney of IgAN patients. The open circle
in the graphs represents the relative quantity
of TCR Vb RT-PCR products from PBL (P)
and kidney (K) of 14 individual IgAN patients,
measured by luminosity. Relative quantity of
each individual Vb RT-PCR product ex-
pressed as a percentage of the total luminosity
of all Vb segments combined. ***P , 0.001
(Vb 8); **P , 0.01(Vb 10); *P , 0.05 (Vb13,
Vb16, Vb18).
Analysis of usage of TCR Vb by T cells infiltrating elected to study this Vb subfamily in more detail. Vb8
the kidneys of IgAN patients TCR expression was significantly increased in IgAN kid-
ney biopsies compared with that seen in PBLs from bothThe TCR repertoire of infiltrating T cells in renal
IgAN patients and healthy controls (P , 0.001; Fig. 4).biopsies and of PBLs from the stable and progressive
Figure 5 shows that relative TCR Vb8 expression ingroups of IgAN patients was then studied. Expression
kidney was significantly more in the progressive groupof all 21 TCRVb families was detected in both the kidney
than in the stable group (P , 0.05). These results indicateand in PBLs of IgAN patients. Figure 3 depicts graphi-
that in IgAN, although the TCR Vb repertoire in T cellscally the results of the relative expression of TCR Vb
infiltrating the kidney is diverse, there is some preferen-in both the kidney and in PBLs of 14 IgAN patients,
tial use of Vb8, particularly in progressive disease.and shows the relative quantity of individual Vb families
expressed as a percentage of the total luminosity of all
CDR3 size spectratypingVb RT-PCR segments combined. Vb8 and Vb13 relative
To determine the length heterogeneity of the CDR3expressions (proportion) were significantly increased in
region of the TCR Vb8 RT-PCR products preferentiallythe kidney (P , 0.001 and P , 0.05), whereas Vb10,
used by infiltrating T cells in the kidney from individualVb16, and Vb18 were decreased (P , 0.01, P , 0.05
patients, TCR Vb8 PCR products from the kidney andand P , 0.05). Because the most striking difference was
observed in Vb8 (8.4% in kidney vs. 3.7% in PBLs), we PBLs from individual patients were spectratyped. Gorski
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Fig. 4. TCR Vb8 expression was significantly increased in IgAN kidney
biopsies (N 5 14) compared with PBLs from both IgA nephropathy
Fig. 6. CDR3 spectratype analysis of TCR Vb8 RT-PCR productspatients (N 5 14) and healthy controls (N 5 24). The relative quantity
from infiltrating T cells in the kidney and from T cells in PBL fromof each Vb8 RT-PCR product is expressed as a percentage of the
patient 3050 with IgAN. Vb8 RT-PCR products were run on a polyacryl-total of all Vb segments combined. Results are plotted as the mean of
amide gel and stained with silver. Spectratypes representing an intenseduplicate samples.
band of Vb8 in kidney with the shortest CDR3 are indicated by an
arrowhead.
et al have reported that, in general, most families of TCR
Vb used by normal PBLs show a Poisson distribution of
intensities on CDR3 spectratyping; that is, the central
bands on the gel are the most intense, and the CDR3
sizes either larger and smaller than the mean contribute
less to the overall repertoire [24]. CDR3 spectratyping
analysis of our samples revealed that Vb8 expression in
the majority of kidneys of patients with IgAN usually
involved a diverse group of CDR3, but it was interesting
that kidney biopsy spectratypes of Vb8 from four pa-
tients showed a most intense band at the bottom of the
spectratype (the shortest CDR3). In PBLs from the same
patients, the CDR3 spectratype showed a normal pattern
as a Poisson distribution of intensities, and the equivalent
spectratype band in size to the strongest band from kid-
ney was much less intense, as shown in Figure 6. These
results suggest that the Vb8-positive T cells infiltrating
the kidneys of some patients with IgAN may use a re-
stricted subset of the Vb8 family with a short CDR3.
Sequencing analysis of Vb8 PCR products
To identify the b-chain CDR3 amino acid sequence
Fig. 5. Increased TCR Vb8 expression was seen in renal biopsies of across the variable, diversity and joining (VDJ) junctions
progressive group compared with stable group (N 5 7). Relative quan- of TCR Vb8 from T cells infiltrating IgAN kidneys, we
tity of each Vb8 RT-PCR product expressed as a percentage of the
next subcloned and sequenced individual reamplifiedtotal of all Vb segments combined. Results are plotted as mean of
duplicate samples. PCR products from excised intense bands from T cells
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Table 1. Junctional sequences of T cell receptor (TCR) Vb8 RT-PCR products from T cells infiltrating the kidney in IgAN
Vb8 N-D-N Jb
71 75 85
Clonotype CDR3
Patient no. | b - - - - - - - - - CDR3 - - - - - - - - c | frequency length
3050 (IB)a CAS S LGH EQF FG Jb2.1 10/10 7
3018 (IB) CAS S LDD EQF FG Jb2.1 3/3 8
3042 (IB) CAS S L T S Y EQF FG Jb2.1 3/3 8
3049 (IB) CAS S LVYN EQF FG Jb2.1 2/3 8
CAS S S GV YEQY FG Jb2.7 1/3 8
3050 CAS S LGH EQF FG Jb2.1 17/20 7
CAS S F PGYG E L F FG Jb2.2 2/20 9
CAS S YR S YEQY VG Jb2.7 1/20 8
a IB is intense band. The sequences in the upper portion derive from the Vb8 spectratype intense band from four patients. The sequences in the lower portion
derive from cDNA encoding Vb8 from all of the RT-PCR products from T cells infiltrating the kidney from patient 3050. The conserved amino acids are in bold
type. CDR3 including the 59 S residue of the conserved C-A-S-(S) motif of most TCRVb genes and the 39 amino acid that precedes the conserved (X)-F-G-X-G
motif present in all TCR Jb genes [28].
infiltrating kidneys of four IgAN patients. For patient to 4 amino acids (6 to 12 base pairs) shorter than most
3050, we also cloned and sequenced Vb8 PCR products of the clones encoding the Vb8 segments. These data
obtained directly from cDNA without spectratyping. The show that the result seen in the kidney was not influenced
deduced amino acid sequences are shown in Table 1. by the size of the CDR3 fragment cloned. It should be
Sequencing of the Vb8 PCR product derived from the noted that most b-chain spectratypes show a 3 bp spac-
intense spectratype band from T cells infiltrating the kid- ing. These data are precisely consistent with the results
ney of patient 3050 demonstrated that 10 of 10 clones seen on spectratyping of Vb8 PCR products in PBL (Fig.
shared an identical Vb8 CDR3 at the nucleotide se- 6). The CDR3 length of the central most intense bands
quence level, suggesting that they are all derived from is 9 to 11 amino acids: 2 to 4 amino acids (6 to 12 bp)
a single progenitor cell. As shown in the lower portion longer than the less intense bands at the bottom.
of Table 1, CDR3 sequences obtained directly from the Sequence analysis of Vb8 PCR products excised from
Vb8 RT-PCR products of patient 3050 without spec- Vb8 intense bands amplified from cDNA of kidneys from
tratyping were, as might be expected, more heteroge- patients 3018, 3042, and 3049 also showed oligoclonality
neous, but the Vb8 sequencing still showed usage of the in the CDR3 region (the upper portion of Table 1). These
same clone as the one from the intense band at a remark- results further suggest that there is a preferential use of
able frequency of 17 clones of the 20 that were sequenced Vb8 expression with marked similarities in the CDR3
(85%). These data further confirm the Vb8 spectratype region composition in some renal infiltrating T cells.
results, that kidney-derived T cells are using a very lim- The most interesting finding is that sequencing of Vb8
ited subset of Vb8 with a relatively short CDR3 in patient genes of kidney intense bands from four patients revealed
3050. In contrast, Table 2 shows that a similar analysis such a high concordance across the CDR3 region (Table 1).
of the CDR3 region of TCR Vb8 RT-PCR products in Eighteen of 19 clones shared an identical Jb2.1 sequence.
PBL from patient 3050 revealed highly diverse se- A leucine residue was conserved at the first position of
quences: 20 clones had 18 different CDR3 sequences. the ND region in 18 of 19 clones (95%). Glutamic acid
Sequence analysis of cDNA encoding the Vb8 products and glutamine at positions 85 and 86 were present in 19
of PBL in patient 3050 with IgAN showed that not one clones of 19 clones (100%). These results suggest that
of 20 clones demonstrated the same sequence as that infiltrating T cells bearing TCR Vb8 with short CDR3s
seen repeatedly in the kidney of that patient (the lower in the kidney might recognize limited epitopes of an
portion of Table 2). The CDR3 length of most of the 20 antigen presented in the kidney and may be proliferating
clones from PBL was from 9 to 11 amino acids, which locally in response to that antigenic stimulus.
equates to the size seen in the center of the spectratype
bands (Fig. 6). We then cloned and sequenced PBL Vb8
DISCUSSIONRT-PCR products derived from that portion of the
Our studies are the first, to our knowledge, to analyzeCDR3 spectratype from patient 3050, which was equiva-
TCR Vb repertoire in kidney biopsies of patients withlent in size to the intense band seen in the kidney, and
IgAN. The data obtained show that the TCRs detecteddemonstrated that of nine clones, each had different
in renal biopsies of patients with IgAN are diverse andCDR3 amino acid sequences (shown in the upper portion
indicate essentially a polyclonal response. However,of Table 2). Only one of the nine clones was the same
as in the kidney. CDR3 length was 7 amino acids and 2 preferential expression of TCR Vb8 by renal infiltrating
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Table 2. Junctional sequences of TCR Vb8 RT-PCR products from peripheral blood T cells of an IgAN patient
Vß8 N-D-N Jb
75 85
Patient Clonotype CDR3
no. | b - - - - - - - - CDR3 - - - - - - - - c | frequency length
3050* CAS T F VD EQF FG Jb2.1 1/9 7
CAS S S DD EQF FG Jb2.1 1/9 7
CAS S LGH EQF FG Jb2.1 1/9 7
CAS S S T YEQY FG Jb2.7 1/9 7
CAS S P S YEQF FG Jb2.7 1/9 7
CAS S PWG GYT FG Jb1.2 1/9 7
CAS S S TV PQQ FG Jb2.1 1/9 7
CAS S FAN EAF FG Jb1.1 1/9 7
CAS S I D YEQY FG Jb2.7 1/9 7
3050 CAS S PDR S S YN EQF FG Jb2.1 1/20 11
CAS R YDGLAERDTG E L F FG Jb2.2 1/20 14
CAS S I P P P YN QY FG Jb2.7 1/20 9
CAS S LVGAA YEQY FG Jb2.7 3/20 10
CAS S LVGAT YEQY FG Jb2.7 1/20 10
CAS S F RGVQ EQF FG Jb2.1 1/20 9
CAS S LWEAPG E L F FG Jb2.2 1/20 10
CAS T GD S Y GYT FG Jb1.2 1/20 9
CAS S P TAGF GNT I Y FG Jb1.3 1/20 11
CAS S LAGG NQPQH FG Jb1.5 1/20 10
CAS S L F V NQPQH FG Jb1.5 1/20 9
CAS G HP FW GYT FG Jb1.2 1/20 8
CAS S L TAGK T I Y FG Jb1.3 1/20 9
CAS S P TAGAT YEQY FG Jb2.7 1/20 11
CAS S F KGGR I N EQF FG Jb2.1 1/20 11
CAS S LG I GRAG TQF FG Jb2.3 1/20 11
CAS S FGD S S L E T P I FG Jb2.5 1/20 11
CAS S LKDRE S F Y EKL F FG Jb1.4 1/20 13
* The sequences in the upper portion derive from an excised Vb8 spectratype band from PBL of 3050 patient equivalent in size to the strongest Vb8 spectratype
band from the kidney on polyacrimide gel. The sequences in the lower portion derive from cDNA encoding Vb8 direct RT-PCR products from 3050 PBL.
T cells was observed in most renal biopsies of patients toire in our study is that the majority of the TCR reper-
toire in the diseased kidney could reflect recruitment ofwith IgAN. Vb8 was particularly overexpressed in the
renal biopsies of patients whose disease had progressed T lymphocytes to a general inflammatory process. This
hypothesis is consistent with the immunologic notion ofto renal impairment. Junctional sequencing of PCR Vb8
products derived from CDR3 spectratype showed high determinant spreading [26, 27]. Initial autoreactive T
cells recognize a single immunodominant epitope andsimilarities across the CDR3 region, suggesting that this
interesting subset of Vb8 T cells may be proliferating in use a restricted TCR V gene repertoire. After antigen
recognition, activated T cells are capable of modulatingresponse to a particular antigen or set of antigens.
The results in this study further confirm the results of a wide range of secondary immune events through up-
regulation of costimulatory molecules and the release ofour previous study [17], which demonstrated that both
ab and gd T cells were found in the interstitium of stable lymphokines, leading to the broadening of the initially
restricted T-cell response, exposure of previously crypticand progressive IgAN kidneys, but significantly more
were present in the progressive group than the stable antigenic determinants, and eventually to the influx of
a variety of T cells and other nonspecifically recruitedgroup. In the present study, Vb8 expression was in-
creased in most IgAN kidney biopsies, but was signifi- cells. A renal biopsy in IgAN usually represents a rela-
tively advanced time point in a chronic disease. The TCRcantly expressed to a greater extent in kidneys with pro-
gressive IgAN than in stable kidneys. Recent studies repertoire in the kidneys in the acute phase may be more
restricted.from several groups on the role of infiltrates in IgAN
found that T cells in the interstitium are strongly corre- The significant increase in TCR Vb8 in most of the
IgAN kidney biopsies tested in this study may be thoughtlated with the degree of histologic injury and renal dys-
function at the time of biopsy [12, 13, 16]. These findings, surprising, as the 14 patients seem very unlikely to have
the same major histocompatibility complex (MHC) hap-together with our results concerning Vb81 T cells, sug-
gest that Vb81 T cells may be involved in the progression lotypes. The observation may imply the involvement of
superantigens. Choi et al have reported that T cells ex-of renal injury in some patients with this disease.
A possible explanation for the diversity of TCR reper- pressing certain Vb families can be stimulated by bacte-
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rial toxins such as staphylococcal enterotoxin and toxic of the ND region associated with preferential usage of
Jb2.1. Because the CDR3 region (from a currently pro-shock syndrome toxin acting as superantigens [20], and
others have observed that particular superantigens inter- posed TCR structure) [43, 45, 46] is thought to interact
with the antigenic peptides bound within a groove onact with particular TCR Vb subfamilies [28, 29]. Super-
antigens have been implicated previously in human auto- the molecules of MHC during conventional antigen rec-
ognition, the conservation of amino acid sequences at theimmune diseases [30]. For example, Vb71 and Vb141 T
cells expanding in the synovial fluid of patients with CDR3 within a group of CDRs is indicative of antigen
specificity [47]. Our observation means that it is likelyrheumatoid arthritis are thought to be responding to
superantigen [31, 32]. Conrad et al reported that Vb7- that certain Vb8 T cells are proliferating in response
to antigen-driven stimulation through the trimolecularpositive T cells accumulated in the pancreas of patients
with insulin-dependent diabetes mellitus and that these MHC/antigen/TCR complex. Conserved amino acids in
the CDR3 region may contribute to the recognition ofcells expand in response to a pancreatic islet cell mem-
brane-bound superantigen [33]. It is interesting to note a particular antigen or a set of antigens. The fact that
specific antigens have also been detected in the kidneythat TCR Vb2 was expressed predominantly on infiltrat-
ing T cells in the kidneys of six Sjo¨gren’s syndrome pa- [39–42] makes it less surprising that specific TCR should
also be present. It is interesting to note that IgAN pa-tients, and the junctional sequence of Vb2 PCR products
has shown some conserved amino acids in the CDR3 tients immunized with tetanus toxoid preferentially pro-
duce IgA isotype antitetanus toxoid antibodies [48, 49],region, although these patients presented different hu-
man lymphocyte antigen (HLA) haplotypes [34]. Several and stimulation of T cells with tetanus toxoid as a nomi-
nal antigen results in a highly restricted CDR3 profilegroups have reported that superantigens preferentially
stimulate T cells using TCR Vb2, Vb4, and Vb8 [28, in TCR Vb families after three rounds of culture [28].
A similar mechanism may be operating to produce clonal35–37]. In IgAN, the typical clinical pattern of rapid
onset macroscopic hematuria in response to infection or expansion of individual T cells in some patients with
IgAN.antigenic challenge at mucous membranes is consistent
with a preformed antibody response to the common bac- In conclusion, we have demonstrated that T cells infil-
teria that infect the respiratory tract [38] and the gastro- trating the renal interstitium of patients with IgAN ex-
intestinal tract [15, 39]. Specific antigens have also been press heterogeneous T cell receptors, consistent with a
detected in the kidneys of patients with IgAN [39–42]. polyclonal response. The preferential use of Vb8 with
In the context of these reported findings, our observation marked similarities in CDR3 sequences in some renal
of increased Vb8 expression in most kidney biopsies infiltrating T cells suggests that there is a clonal expan-
tested across different MHC types in IgAN seems biolog- sion of individual T cells in the kidney of some IgAN
ically plausible. patients. Conserved amino acids in the CDR3 region
The fine specificity of conventional antigen recogni- may contribute to the recognition of a particular antigen
tion by T cells is determined by the CDR3 region of the or a set of antigens.
TCR. The length of the CDR3 segment of members of
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bearing T cells with a short CDR3 exists in the kidneys
Abbreviations used in this article are: EAE, experimental allergicof some patients. To define the clonotype further, we
encephalomyelitis; GFR, glomerular filtration rate; IgAN, IgA ne-
sequenced PCR products excised from spectratype bands. phropathy; PBL, peripheral blood lymphocyte; RT-PCR, reverse tran-
scription-polymerase chain reaction; TBR, tris (2,29-bipyridine) ruthe-The most striking observation in our study concerns
nium (II) chelate; TCR, T cell receptor.the sequence analyses of Vb8 CDR3 expressed in renal
biopsies from four IgAN patients, which revealed marked
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